| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
32 |
| Employees |
5,400 |
| Revenues (TTM) (Millions $) |
708 |
| Net Income (TTM) (Millions $) |
-38 |
| Cash Flow (TTM) (Millions $) |
67 |
| Capital Exp. (TTM) (Millions $) |
13 |
Business Description
Alerislife Inc is a privately-held biotechnology company that focuses on the discovery and development of innovative autoimmune therapies.
The company was founded in 2015 by a team of experienced biotechnology executives and is based in Cambridge, Massachusetts.
The main focus of Alerislife Inc is on developing therapies that target the root causes of autoimmune diseases rather than treating their symptoms.
The company's approach is based on the science of immunometabolism, which involves targeting the metabolic pathways that regulate the immune system.
Alerislife's lead candidate is AL001, a small molecule drug that targets the remyelination of damaged nerves in patients with multiple sclerosis.
The company also has several other development programs in the pipeline, including candidates for lupus, rheumatoid arthritis, and inflammatory bowel disease.
Alerislife's team is made up of experienced industry veterans and leading scientists in the field of immunology and metabolic disease.
The company's management team includes CEO, Dr.
Tariq Kassum, who has over 20 years of experience in the biopharmaceutical industry.
Additionally, the company has world-renowned immunologists and metabolic disease experts on its scientific advisory board.
In addition to their drug development programs, Alerislife is also developing biomarker assays that could be used to identify patient subtypes and predict response to treatment.
These biomarkers would allow the company to develop personalized treatments that are tailor-made for each patient.
Overall, Alerislife brings a unique approach to developing autoimmune therapies that has the potential to transform the way autoimmune diseases are treated.
With a strong team of experts, innovative science, and promising drug development programs, Alerislife has positioned itself as a leader in this field.
Company Address: Two Newton Place, 255 Washington Street, Newton 2458 MA
Company Phone Number: 796-8387 Stock Exchange / Ticker: NASDAQ ALR
|
%
